Mediland Pharm Limited announced earnings results for the full year ended June 30, 2020. For the full year, the company announced sales was AUD 23.298 million compared to AUD 30.661 million a year ago. Net loss was AUD 5.109 million compared to AUD 11,244 a year ago. Basic loss per share was AUD 0.0163 compared to AUD 0.0001 a year ago.